ONXX Related Trading Halts
-
Onyx Pharmaceuticals (ONXX) Resumes Trading, Now Up 8.4%
-
Shares of Onyx Pharma (ONXX) to resume trading at 12:50pm ET
-
Onyx Pharma (ONXX) Affirms Getting FDA Aproval for Kyprolis
-
Onyx Pharma's (ONXX) Kyprolis Receives FDA Approval as Multiple Myeloma Treatment
-
UPDATE: Onyx Pharmaceuticals (ONXX) Kyprolis approved
-
Onyx Pharmaceuticals (ONXX) halted, news pending
-
Onyx Pharma (ONXX) shares resume trading around $60, up 34%
-
Onyx Pharmaceuticals (ONXX) Set to Resume Trading at 7:15AM ET
-
FDA Panel votes 11-0 benefits outweigh risks of Onyx's (ONXX) carfilzomib
-
Onyx Pharma (ONXX) Affirms Trading Halt Ahead of FDA Meeting on NDA for Kyprolis
-
Onyx Pharmaceuticals, Inc. (ONXX) trading halted with news pending
Back to ONXX Stock Lookup
